Heron Therapeutics Announces Upcoming Financial Results Call

Author: Dylan Bailey Updated: 02-13-2025 05:02 PM

Heron Therapeutics Prepares for Financial Reporting

Heron Therapeutics, Inc. (NASDAQ: HRTX) is gearing up for an important event where the company will share its financial results for the fourth quarter and full year of 2024. This anticipated conference call will take place on Thursday, February 27, 2025, at 8:00 a.m. ET.

Joining the Conference Call

The call will be accessible via a phone registration system, and participants are encouraged to join fifteen minutes before it begins. This is a great opportunity for investors and stakeholders to gain insights into the company's latest financial performance and strategy. Additionally, the call will be available on Heron's website under the Investor Relations section. An archived version will also be accessible for 60 days following the event.

Heron Therapeutics: Who They Are

Heron Therapeutics is committed to enhancing patient care through innovative biotechnology solutions. With a focus on developing cutting-edge therapies, the company utilizes advanced science and patented technologies to create a range of products. Heron aims to set new standards in medical care, particularly for patients requiring acute care and those undergoing oncology treatments.

Employee Insights and Company Culture

At the heart of Heron Therapeutics is a dynamic team of professionals who are driven by a shared commitment to making a difference in the field of healthcare. The collaborative atmosphere encourages innovation and promotes a culture where new ideas can flourish. Employees are deeply engaged in their mission of helping patients, demonstrating a shared passion for excellence in therapeutic advancements.

Future Directions and Innovations

As Heron Therapeutics looks towards the future, there is a clear focus on expanding their portfolio of therapeutic options. The company’s ongoing research and development efforts aim to address significant gaps in patient care. By continuing to innovate, Heron seeks to provide effective solutions that can radically transform treatment approaches in various medical areas.

Frequently Asked Questions

What is the purpose of the upcoming conference call for Heron Therapeutics?

The call aims to disclose the financial results for Q4 and the full year of 2024, along with discussing business highlights.

What time will the conference call take place?

The conference call is scheduled for 8:00 a.m. ET on February 27, 2025.

How can participants join the call?

Participants can join by using a registration link that provides necessary dial-in details and should aim to connect fifteen minutes early to avoid delays.

Where can I find more information about Heron Therapeutics?

For more details about the company and its offerings, you can visit Heron Therapeutics' official website.

Who should I contact for investor relations?

Ira Duarte, the Executive Vice President and Chief Financial Officer, is the point of contact for investor relations and media inquiries.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.